BACKGROUND Trigeminal neuralgia is characterized by paroxysmal facial pain attacks. Adequate prophylactic drug therapy is often limited by the lack of efficacy and intolerance due to central nervous system side effects. Subcutaneous injections of botulinum toxin type A are a promising treatment option for patients with unsatisfactory response to drug therapy or neurosurgical intervention. Its e...

PURPOSE The purpose of the study was to evaluate the effectiveness of microvascular decompression treatment prospectively in 40 patients with trigeminal neuralgia who were resistant to medical treatments and underwent microvascular decompression surgery (MVDS) between the years 2008 and 2010. METHODS The patients' data were collected as per norms suggested by Zakrzewska and Lopez and followed...

Objetivo: Realizar um levantamento bibliográfico sobre a Neuralgia do Trigêmeo e o uso dos fármacos Carbamazepina Lamotrigina no seu tratamento. Métodos: Foi realizada uma busca seleção de artigos científicos que abordassem temática assunto, ‘’o medicamentos tratamento da neuralgia trigêmeo’’. Os descritores selecionados para foram: “neuralgia trigêmeo” (trigeminal neuralgia), ‘’Carbamazepina’’...

Reported are a total of 81 microsurgical operations for cranial nerve root decompression comprising of 66 trigeminal, 10 facial, one vestibular, one vagus and three accessory nerve dysfunction syndromes from 1983 to 1990. Almost all cases of trigeminal neuralgia (TNG) secondary to vascular (59 cases) and minute mass (10 cases) compression, and those with hemifacial spasm (HFS) (nine out o...

BACKGROUND Vagal nerve stimulation (VNS) for refractory epilepsy is well established. Trigeminal neuralgia itself is a common disease in adults, and thus, late-onset pain in the trigeminal region under VNS, which is extremely rare, may not be recognized as caused by VNS. CASE PRESENTATION Two patients with drug-resistant symptomatic epilepsy treated with chronic VNS experienced stimulation-re...